Skip to content

Welcome to Discover Pharma! Today is : November 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI imaging

  • Advanced Therapies,Clinical & Regulatory,Digital & Data,Research & Development,Therapeutic Areas

    Brainomix to present five ILD studies on quantitative CT at ERS Congress

    Brainomix will present five studies examining quantitative CT biomarkers in [...]

    August 25, 2026
  • Digital & Data

    Qureight expands London operations to develop AI chest imaging model

    Qureight has opened a second UK site in London as [...]

    August 19, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Qureight raises $20 million to expand AI imaging platform into new lung and heart diseases

    Qureight has raised $20 million in a Series B financing [...]

    July 30, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Qureight raises $20 million to expand AI imaging platform for clinical trials

    Qureight has raised $20 million in a Series B financing [...]

    July 29, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data

    Qureight AI imaging to power Calluna’s Phase 2 IPF trial

    Qureight, a techbio company advancing the understanding of lung and [...]

    May 5, 2026
  • Clinical & Regulatory

    Rein Therapeutics to integrate Qureight’s Deep-Learning Imaging Platform in Upcoming IPF Trial

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neurizon advances NUZ-001 ALS trial into treatment extension
    Categories: Clinical & Regulatory
  • ViiV HIV medicines receive positive EU opinion for younger children
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Ofichem agrees to acquire US CDMO Kinentia Biosciences
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top